Next Article in Journal
Ciguatera in Mexico (1984–2013)
Next Article in Special Issue
Biosynthetic Potential of a Novel Antarctic Actinobacterium Marisediminicola antarctica ZS314T Revealed by Genomic Data Mining and Pigment Characterization
Previous Article in Journal
Enhanced Adhesion of Fish Ovarian Germline Stem Cells on Solid Surfaces by Mussel-Inspired Polymer Coating
Previous Article in Special Issue
Chrysoxanthones A–C, Three New Xanthone–Chromanone Heterdimers from Sponge-Associated Penicillium chrysogenum HLS111 Treated with Histone Deacetylase Inhibitor
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

Discovery of an Unusual Fatty Acid Amide from the ndgRyo Gene Mutant of Marine-Derived Streptomyces youssoufiensis

1
Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China
2
Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao 266237, China
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2019, 17(1), 12; https://doi.org/10.3390/md17010012
Submission received: 19 December 2018 / Revised: 24 December 2018 / Accepted: 24 December 2018 / Published: 28 December 2018
(This article belongs to the Special Issue Genome Mining and Marine Microbial Natural Products)

Abstract

:
NdgRyo, an IclR-like regulator, was selected as the target gene to activate new secondary metabolites in the marine-derived Streptomyces youssoufiensis OUC6819. Inactivation of the ndgRyo gene in S. youssoufiensis OUC6819 led to the accumulation of a new fatty acid amide (1), with an unusual 3-amino-butyl acid as the amine component. Moreover, its parent fatty acid (2) was also discovered both in the wild-type and ΔndgRyo mutant strains, which was for the first time isolated from a natural source. The structures of compounds 1 and 2 were elucidated by combination of LC-MS and NMR spectroscopic analyses. This study demonstrated that the ndgRyo homologs might serve as a target for new compound activation in Streptomyces strains.

Graphical Abstract

1. Introduction

Marine Streptomyces have evolved unique abilities to adapt to the marine environment, which ensures their survival in extreme habitats (e.g., low temperature, high pressure, and poor nutrients) and provides a variety of novel secondary metabolites [1]. With the increase in the number of sequences deposited in microbial genome databases, an increasing number of secondary metabolite biosynthetic gene clusters have been disclosed; however, the majority of them are silent or barely expressed under ordinary laboratory conditions [2]. Thus, activation of silent gene clusters has become an effective strategy for natural product discovery, attracting more and more scientists to this research field.
Secondary metabolism of Streptomyces is controlled by a complicated and elaborate regulatory network [3,4]. The precursors for the biosynthesis of secondary metabolites are usually derived from primary metabolism. Manipulation of the regulators in central metabolism has a far-reaching impact on the production of secondary metabolites [5]. The IclR-like global regulator, ndgR, is a representative of this metabolism that is involved in amino acid metabolism and conserved among Streptomyces species as well as other actinomycetes [6]. Disruption of ndgR in Streptomyces coelicolor led to defective differentiation and enhanced actinorhodin production in minimal media containing certain amino acids [7]. In Streptomyces clavuligerus, deletion of areB, a homolog of ndgR, resulted in increased production of clavulanic acid and cephamycin C [8].
In our effort to discover novel natural products from the marine-derived Streptomyces youssoufiensis OUC6819 by genome mining [9,10], the ndgRyo gene was selected as a target for compound activation. The disruption of the ndgRyo gene caused accumulation of a new fatty acid amide (1) that shares similar UV spectrum with its parent fatty acid (2) present in the wild-type strain (Figure 1). Herein, we describe the isolation, structure elucidation as well as biological evaluation of compounds 1 and 2 from the ΔndgRyo mutant of S. youssoufiensis OUC6819.

2. Results and Discussion

The ndgRyo gene was identified from the S. youssoufiensis OUC6819 genome using the local BlastP program. NdgRyo harbors a Helix-Turn-Helix motif at the N-terminus, and displays 57% identity to the NdgR from S. coelicolor (NP_629686.1). A positive cosmid, pWLI551, was obtained through genome library screening (Table S2). The ΔndgRyo mutant was obtained using a PCR-targeting strategy, as described in the Section 3.4. The fermentation broths of the wild-type and the ΔndgRyo mutant strains were extracted with ethyl acetate, and were subsequently subjected to HPLC analysis (Figure 2). The newly accumulated compound 1 in the ΔndgRyo mutant showed similar UV spectra with that of 2 (Figure 2), indicating they might belong to the same compound class. Large scale fermentation of the ΔndgRyo mutant resulted in the isolation of compounds 1 and 2, followed by identification by NMR spectroscopy.
Compound 1 was isolated as a yellow oil. The molecular formula of 1 was established as C22H35NO4 (five degrees of unsaturation), as determined by HR-ESIMS data (m/z 378.2654 [M + H]+, calcd 378.2644) (Figure S1). The structure of 1 was determined from the 1D and 2D NMR (COSY, HSQC, HMBC, and NOESY) data (Figures S2–S7). The 1H and HSQC spectra of 1 disclosed six methyl groups (δH 1.64, 1.66, 1.78, 0.83, 1.63, and 1.21), three methylenes (δH 2.95, 2.82, 2.54), three methines (δH 2.71, 3.72, and 4.26), and five olefinic protons (δH 5.36, 5.57, 6.12, 5.33, and 5.46). The COSY spectrum established five spin systems of H-2 (δH 2.95)/H-3 (δH 5.36), H-5 (δH 2.82)/H-6 (δH 5.57)/H-7 (δH 6.12), H-9 (δH 5.33)/H-10 (δH 2.71)/H-11 (δH 3.72)/H-17 (δH 0.83), H-13 (δH 5.46)/H-14 (δH 1.64), and H-2′ (δH 2.54)/H-3′ (δH 4.26)/H-4′ (δH 1.21) (Figure 3). The HMBC correlations from H-13 and H-9 to the hydroxylated carbon C-11 (δC 82.3), from H-11 to C-12 (δC 136.7), from H-7 to C-9 (δC 134.4), from H-6 to C-8 (δC 133.7), from H-2 to C-4 (δC 138.4) and a carbonyl carbon C-1 (δC 172.4), from H-5 to C-3 (δC 117.3), from H-3′ to C-1, and from H-2′ to C-1′ (δC 173.2) established the main carbon chain of 1 (Figure 3). The HMBC correlations from the methyl protons H-15 (δH 1.66) to C-5 (δC 42.5), H-16 (δH 1.78) to C-9, H-17 to C-11, and H-18 (δH 1.63) to C-13 (δC 121.4), together with the COSY correlations of H-13/H-14 and H-3′/H-4′, confirmed the location of six methyl groups (Figure 3). The 13C chemical shifts of C-3′ (δC 42.2) and C-1, together with the HR-ESIMS data of 1, revealed the presence of an amide group. Moreover, the configurations of the four double bonds were confirmed to be E by NOESY correlations between H-3/H-5, H-5/H-7, H-7/H-9, H-11/H-13, H-2/H-15, H-6/H-16, and H-10/H-16 (Figure 4). The relative configuration between H-10 and H-11 was proposed to be trans by the large coupling constant value of 8.4 Hz. Then, the absolute configurations of C-10 and C-11 were determined by comparison of the experimental ECD spectra of 1 and 2 (Figure S15) with calculated ECD spectra of the (2E,4E,8E)-7-methoxy-4,6,8-trimethyldeca-2,4,8-triene moiety reported in the literature [11], which showed high agreement with the 10R, 11R calculated model. Thus, compound 1 was identified as 3-((3E,6E,8E,10R,11R,12E)-11-hydroxy-4,8,10,12-tetramethyltetradeca-3,6,8,12-tetraenamido) butanoic acid, a new branched-chain fatty acid amide with 3-amino-butyl acid as the amine component. The 1H and 13C chemical shifts of compound 1 were shown in Table 1.
Compound 2 was isolated as a yellow oil. The molecular formula of 2 was established as C18H28O3 (five degrees of unsaturation), as determined by HR-ESIMS data (m/z 310.2397 [M + NH4]+, calcd 310.2382) (Figure S8). The structure of 2 was determined from the 1D and 2D NMR (COSY, HSQC, HMBC, and NOESY) data (Figures S9–S14). According to the 1H and 13C NMR data (Table 1), compound 2 lacked the 3-amino-butyl acid moiety compared to 1. Moreover, the NOESY correlations (H-3/H-5, H-5/H-7, H-7/H-9, H-11/H-13, H-2/H-15, H-6/H-16, and H-10/H-16) as well as the experimental ECD spectrum revealed that compound 2 displays the same absolute configurations with 1. Thus, compound 2 was identified to be the parent fatty acid of 1, named (3E,6E,8E,10R,11R,12E)-11-hydroxy-4,8,10,12-tetramethyltetradeca-3,6,8,12-tetraenoic acid, which is available from Aurora Fine Chemicals in the United States. Noticeably, this is the first time that compound 2 has been isolated from a natural source.
In the antibacterial activity evaluation of compounds 1 and 2, neither of them showed obvious inhibitory effects, in the range of concentrations tested, against the multi-drug resistant (MDR) strains, including Enterococcus faecalis CCARM 5172, Enterococcus faecium CCARM 5203, Staphylococcus aureus CCARM 3090, Escherichia coli CCARM 1009, and Salmonella typhimurium CCARM 8250. Some branched-chain oleic acid derivatives exhibited growth inhibition against MCF-7 and HT-29 cells [12]. Therefore, we also tested the cytotoxicity of compounds 1 and 2 against these two cell lines, but they showed null activity up to the concentration of 50 µM (data not shown).
Fatty acid amides are a class of compounds formed from a fatty acid and an amine that play an important role in intracellular signaling, many of which in nature have ethanolamine as the amine component [13,14,15]. Inactivation of the ndgRyo gene in S. youssoufiensis OUC6819 led to the isolation of a new fatty acid amide and (1) and its parent branched-chain fatty acid (2). The 3-amino-butyl acid moiety in 1 is likely to come from l-glutamate [16]. As the IclR-like global regulator, NdgR, is generally involved in amino acid metabolism [6], we proposed that ndgRyo in S. youssoufiensis OUC6819 might contribute to the generation of the unusual branched-chain fatty acid amide (1) with an amino acid as the amine component.

3. Materials and Methods

3.1. General Experimental Procedures

1D (1H and 13C) and 2D (COSY, HSQC, HMBC, and NOESY) NMR spectra were recorded on Bruker Avance III 600 spectrometers at 298 K. The mixing time used for the NOESY spectrum was 142 ms. Chemical shifts were reported with reference to the respective solvent peaks and residual solvent peaks (δH 3.31 and δC 49.0 for CD3OD). HR-ESIMS data were obtained on a Q-TOF Ultima Global GAA076 MS spectrometer. HPLC was performed on an Agillent 1260 Infinity apparatus equipped with a diode array detector (DAD).

3.2. Bacterial Strains and Culture Conditions

Escherichia coli DH5α served as the host for general subcloning [17]. Escherichia coli ET12567/pUZ8002 was used as the cosmid donor host for E. coli-Streptomyces intergenic conjugation [18]. Escherichia coli BW25113/pIJ790 was used for λRED-mediated PCR-targeting [19]. The S. youssoufiensis OUC6819 was isolated from reed rhizosphere soil collected from the mangrove conservation area of Guangdong province, China [9]. E. coli strains were routinely cultured in Luria–Bertani (LB) liquid medium at 37 °C, 200 rpm, or LB agar plate at 37 °C. Streptomyces strains were grown at 30 °C on R2YE medium for sporulation and ISP4 for conjugation, and were cultured in tryptic soy broth (TSB) medium for genomic DNA preparation. Fermentation medium consists of 1% soluble starch, 2% glucose, 4% corn syrup, 1% yeast extract, 0.3% beef extract, 0.05% MgSO4·7H2O, 0.05% KH2PO4, 0.2% CaCO3, and 3% sea salt, pH = 7.0.

3.3. DNA Isolation and Manipulation

Plasmid extractions and DNA purifications were carried out using standardized commercial kits (OMEGA, Bio-Tek, Guangzhou, China). PCR reactions were carried out using Pfu DNA polymerase (TIANGEN, Beijing, China). Oligonucleotide synthesis and DNA sequencing were performed by TSINGKE company (Qingdao, China).

3.4. Gene Inactivation

Positive cosmids harboring the ndgRyo gene were screened against the genomic library of S. youssoufiensis OUC6819 by using PCR with primers listed in Table S1. One cosmid, pWLI551 (Table S2), was obtained and then confirmed by DNA sequencing in TSINGKE company (Qingdao, China). The amplified aac(3) IV-oriT resistance cassette from pIJ773 was transformed into E. coli BW25113/pIJ790 containing pWLI551 to replace an internal region of the target gene, the PCR primers are listed in Table S3. The mutant cosmid was constructed and introduced into S. youssoufiensis OUC6819 by conjugation from E. coli ET12567/pUZ8002 according to the reported procedure, using S. youssoufiensis OUC6819 ultrasonic fragmented mycelia as acceptors [20]. The desired mutants were selected by the apramycin-resistant and kanamycin sensitive phenotype, and were confirmed by PCR (Figure S16), using the primers listed in Table S4.

3.5. Isolation and Purification of the Compounds

The fermentation broth (50 mL) of the S. youssoufiensis OUC6819 strains was extracted twice with an equal volume of ethyl acetate, and subsequently subjected to the HPLC analysis. Analytical HPLC was performed on a YMC-Pack ODS-A column (5 μm, 4.6 × 150 mm) developed with a linear gradient from 20% to 100% B/A in 45 min (phase A: H2O; phase B: 100% acetonitrile) at the wavelength of 220 nm. The culture broth (15 L) of a scaled-up culture of the ΔndgRyo mutant was extracted with ethyl acetate and evaporated at room temperature, which was partitioned between 90% methanol and n-hexane to remove nonpolar components. Compounds 1 (3 mg) and 2 (10 mg) were obtained by separation of the methanol layer with a linear gradient from 70% to 90% B at a flow rate of 2.0 mL/min using a YMC-Pack ODS-A column (5 μm, 120 Å, 250×10 mm; wavelength 220 nm).
Compound 1: Yellow oil; [α] D −8.1 (c 0.1, MeOH); CD (MeOH) λmax (Δε) 202.5 (+5.23), 234.5 (−3.99) nm; 1H and 13C NMR data, see Table 1; HR-ESIMS m/z 378.2654 [M + H]+ (calcd for C22H36NO4, 378.2644).
Compound 2: Yellow oil; [α] D −2.8 (c 0.1, MeOH); CD (MeOH) λmax (Δε) 200.5 (+4.66), 231.5 (−3.51) nm; 1H and 13C NMR data, see Table 1; HR-ESIMS m/z 310.2397 [M + NH4]+ (calcd for C18H32NO3, 310.2382).

3.6. Nucleotide Sequence Accession Number

The nucleotide sequence of ndgRyo in this paper has been deposited in the GenBank database, and the accession number is MH252211.

4. Conclusions

A new fatty acid amide (1) with an unusual 3-amino-butyl acid as the amine component, together with its parent fatty acid (2) were isolated from the ΔndgRyo mutant strain of S. youssoufiensis OUC6819. Compounds 1 and 2 displayed neither inhibitory effects against the five MDR bacterial strains, nor cytotoxicity against MCF-7 and HT-29 cancer cell lines. This study demonstrated that the ndgRyo homologs might serve as a target for activation of structurally novel secondary metabolites in the Streptomyces strains.

Supplementary Materials

The following are available online at https://www.mdpi.com/1660-3397/17/1/12/s1, Supporting Figures S1–S16 and Tables S1–S4, including HR-ESIMS, NMR and ECD spectra of compounds 1 and 2, plasmids and primer lists, and biological assay methods.

Author Contributions

J.H., J.L. and Z.L. performed the experiments. J.H. wrote the draft manuscript. L.Y. was involved in NMR analysis. Q.C., T.Z. and D.L. isolated the Streptomyces strain. W.L. and H.Y. supervised the whole work and wrote the manuscript. All authors read and approved the final manuscript.

Acknowledgments

This work was supported by the National Natural Science Foundation of China under Grants 31570032, 31711530219, 41506157 and 21502180; and the NSFC-Shandong Joint Foundation under Grants U1706206 and U1406403.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Manivasagan, P.; Venkatesan, J.; Sivakumar, K.; Kim, S.K. Pharmaceutically active secondary metabolites of marine actinobacteria. Microbiol. Res. 2014, 169, 262–278. [Google Scholar] [CrossRef] [PubMed]
  2. Rutledge, P.J.; Challis, G.L. Discovery of microbial natural products by activation of silent biosynthetic gene clusters. Nat. Rev. Microbiol. 2015, 13, 509–523. [Google Scholar] [CrossRef] [PubMed]
  3. Lu, C.; Liao, G.; Zhang, J.; Tan, H. Identification of novel tylosin analogues generated by a wblA disruption mutant of Streptomyces ansochromogenes. Microb. Cell Fact. 2015, 14, 173. [Google Scholar] [CrossRef] [PubMed]
  4. Li, Y.; Tan, H. Biosynthesis and molecular regulation of secondary metabolites in microorganisms. Sci. China Life Sci. 2017, 60, 935–938. [Google Scholar] [CrossRef] [PubMed]
  5. Liu, G.; Chater, K.F.; Chandra, G.; Niu, G.; Tan, H. Molecular regulation of antibiotic biosynthesis in Streptomyces. Microbiol. Mol. Biol. Rev. 2013, 77, 112–143. [Google Scholar] [CrossRef] [PubMed]
  6. Kim, J.N.; Jeong, Y.; Yoo, J.S.; Roe, J.H.; Cho, B.K.; Kim, B.G. Genome-scale analysis reveals a role for NdgR in the thiol oxidative stress response in Streptomyces coelicolor. BMC Genom. 2015, 16, 116. [Google Scholar] [CrossRef] [PubMed]
  7. Yang, Y.H.; Song, E.; Kim, E.J.; Lee, K.; Kim, W.S.; Park, S.S.; Hahn, J.S.; Kim, B.J. NdgR, an IclR-like regulator involved in amino-acid-dependent growth, quorum sensing, and antibiotic production in Streptomyces coelicolor. Appl. Microbiol. Biotechnol. 2009, 82, 501–511. [Google Scholar] [CrossRef] [PubMed]
  8. Santamarta, I.; Lópezgarcía, M.T.; Pérezredondo, R.; Koekman, B.; Martín, J.F.; Liras, P. Connecting primary and secondary metabolism: AreB, an IclR-like protein, binds the AREccaR sequence of S. clavuligerus and modulates leucine biosynthesis and cephamycin C and clavulanic acid production. Mol. Microbiol. 2007, 66, 511–524. [Google Scholar] [CrossRef] [PubMed]
  9. Che, Q.; Li, T.; Liu, X.; Yao, T.; Li, J.; Gu, Q.; Li, D.; Li, W.; Zhu, T. Genome scanning inspired isolation of reedsmycins A-F, polyene-polyol macrolides from Streptomyces sp. CHQ-64. RSC Adv. 2015, 5, 22777–22782. [Google Scholar] [CrossRef]
  10. Yao, T.; Liu, Z.; Li, T.; Zhang, H.; Liu, J.; Li, H.; Che, Q.; Zhu, T.; Li, D.; Li, W. Characterization of the biosynthetic gene cluster of the polyene macrolide antibiotic reedsmycins from a marine-derived Streptomyces strain. Microb. Cell Fact. 2018, 17, 98. [Google Scholar] [CrossRef] [PubMed]
  11. Han, X.; Liu, Z.; Zhang, Z.; Zhang, X.; Zhu, T.; Gu, Q.; Li, W.; Che, Q.; Li, D. Geranylpyrrol A and piericidin F from Streptomyces sp. CHQ-64 ΔrdmF. J. Nat. Prod. 2017, 80, 1684–1687. [Google Scholar] [CrossRef] [PubMed]
  12. Dailey, O.D., Jr.; Wang, X.; Chen, F.; Huang, G. Anticancer activity of branched-chain derivatives of oleic acid. Anticancer Res. 2011, 31, 3165–3169. [Google Scholar] [PubMed]
  13. Jain, M.K.; Ghomashchi, F.; Yu, B.Z.; Bayburt, T.; Murphy, D.; Houck, D.; Solowiej, J.E. Fatty acid amides: scooting mode-based discovery of tight-binding competitive inhibitors of secreted phospholipases A2. J. Med. Chem. 1992, 35, 3584–3586. [Google Scholar] [CrossRef] [PubMed]
  14. Blancaflor, E.B.; Kilaru, A.; Keereetaweep, J.; Khan, B.R.; Faure, L.; Chapman, K.D. N-Acylethanolamines: lipid metabolites with functions in plant growth and development. Plant J. 2014, 79, 568–583. [Google Scholar] [CrossRef] [PubMed]
  15. Tuo, W.; Leleu-Chavain, N.; Spencer, J.; Sansook, S.; Millet, R.; Chavatte, P. Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and N-acylethanolamine acid amidase inhibitors. J. Med. Chem. 2016, 60, 4–46. [Google Scholar] [CrossRef] [PubMed]
  16. Takaishi, M.; Kudo, F.; Eguchi, T. A unique pathway for the 3-aminobutyrate starter unit from L-glutamate through β-Glutamate during biosynthesis of the 24-membered macrolactam antibiotic, incednine. Org. Lett. 2012, 14, 4591–4593. [Google Scholar] [CrossRef] [PubMed]
  17. Maniatis, T.; Fritsch, E.F.; Sambrook, J. Molecular Cloning: A Laboratory Manual; Cold Spring Harbor: New York, NY, USA, 1982. [Google Scholar]
  18. Paget, M.S.; Chamberlin, L.; Atrih, A.; Foster, S.J.; Buttner, M.J. Evidence that the extracytoplasmic function sigma factor σE is required for normal cell wall structure in Streptomyces coelicolor A3(2). J. Bacteriol. 1999, 181, 204–211. [Google Scholar] [PubMed]
  19. Gust, B.; Challis, G.L.; Fowler, K.; Kieser, T.; Chater, K.F. PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin. Proc. Natl. Acad. Sci. USA 2003, 100, 1541–1546. [Google Scholar] [CrossRef] [PubMed]
  20. Liu, Z.; Li, T.; Liu, J.; Yao, T.; Zhang, H.; Xia, J.; Li, H.; Che, Q.; Li, W. Development of the genetic system of mangrove derived Streptomyces sp. OUC6819. Chin. J. Mar. Drugs. 2016, 35, 53–59. [Google Scholar]
Figure 1. Structures of compounds 1 and 2.
Figure 1. Structures of compounds 1 and 2.
Marinedrugs 17 00012 g001
Figure 2. HPLC traces of the fermentation products from the S. youssoufiensis OUC6819 strains. (i) The ΔndgRyo mutant; (ii) the wild-type strain. Compound 1 was newly accumulated in the ΔndgRyo mutant strain. Compound 2 was produced in both the wild-type and ΔndgRyo mutant strains, and shares similar UV spectrum with 1.
Figure 2. HPLC traces of the fermentation products from the S. youssoufiensis OUC6819 strains. (i) The ΔndgRyo mutant; (ii) the wild-type strain. Compound 1 was newly accumulated in the ΔndgRyo mutant strain. Compound 2 was produced in both the wild-type and ΔndgRyo mutant strains, and shares similar UV spectrum with 1.
Marinedrugs 17 00012 g002
Figure 3. 1H-1H COSY and key HMBC correlations of 1 in CD3OD.
Figure 3. 1H-1H COSY and key HMBC correlations of 1 in CD3OD.
Marinedrugs 17 00012 g003
Figure 4. Key NOESY correlations of 1 in CD3OD.
Figure 4. Key NOESY correlations of 1 in CD3OD.
Marinedrugs 17 00012 g004
Table 1. 1H (600 MHz) and 13C (150 MHz) NMR chemical shifts of 1 and 2 in CD3OD.
Table 1. 1H (600 MHz) and 13C (150 MHz) NMR chemical shifts of 1 and 2 in CD3OD.
Position12
δH (J in HZ)δC δH (J in HZ)δC
1 172.4 174.9
22.95 (2H, d, 7.2)35.03.06 (2H, d, 7.2)33.0
35.36 (1H, t, 6.6)117.35.39 (1H, t, 6.6)116.7
4 138.4 137.7
52.82 (2H, d, 7.2)42.52.82 (2H, d, 7.2)42.5
65.57 (1H, dt, 15.6, 7.2)124.45.56 (1H, dt, 15.6, 7.2)124.4
76.12 (1H, d, 15.6)136.76.13 (1H, d, 15.6)136.7
8 133.7 133.7
95.33 (1H, d, 9.0)134.45.33 (1H, d, 9.6)134.4
102.71 (1H, m)36.12.71 (1H, m)36.1
113.72 (1H, d, 8.4)82.33.72 (1H, d, 7.8)82.3
12 136.7 136.7
135.46 (1H, q, 6.6)121.45.47(1H, q, 6.0)121.4
141.64 (3H, d, 6.6)11.61.64 (3H, d, 6.0)11.7
151.66 (3H, s)15.01.66 (3H, s)15.0
161.78 (3H, m)11.61.78 (3H, m)11.7
170.83 (3H, d, 6.6)16.60.83 (3H, d, 7.2)16.7
181.63 (3H, s)9.71.63 (3H, s)9.7
1′ 173.2
2′2.54 (1H, dd, 15.6, 6.0)
2.42 (1H, dd, 15.6, 6.0)
40.0
3′4.26 (1H, m)42.2
4′1.21 (3H, d, 6.6)18.8

Share and Cite

MDPI and ACS Style

Hou, J.; Liu, J.; Yang, L.; Liu, Z.; Li, H.; Che, Q.; Zhu, T.; Li, D.; Li, W. Discovery of an Unusual Fatty Acid Amide from the ndgRyo Gene Mutant of Marine-Derived Streptomyces youssoufiensis. Mar. Drugs 2019, 17, 12. https://doi.org/10.3390/md17010012

AMA Style

Hou J, Liu J, Yang L, Liu Z, Li H, Che Q, Zhu T, Li D, Li W. Discovery of an Unusual Fatty Acid Amide from the ndgRyo Gene Mutant of Marine-Derived Streptomyces youssoufiensis. Marine Drugs. 2019; 17(1):12. https://doi.org/10.3390/md17010012

Chicago/Turabian Style

Hou, Jing, Jing Liu, Lu Yang, Zengzhi Liu, Huayue Li, Qian Che, Tianjiao Zhu, Dehai Li, and Wenli Li. 2019. "Discovery of an Unusual Fatty Acid Amide from the ndgRyo Gene Mutant of Marine-Derived Streptomyces youssoufiensis" Marine Drugs 17, no. 1: 12. https://doi.org/10.3390/md17010012

APA Style

Hou, J., Liu, J., Yang, L., Liu, Z., Li, H., Che, Q., Zhu, T., Li, D., & Li, W. (2019). Discovery of an Unusual Fatty Acid Amide from the ndgRyo Gene Mutant of Marine-Derived Streptomyces youssoufiensis. Marine Drugs, 17(1), 12. https://doi.org/10.3390/md17010012

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop